Promising utility of using serial ctDNA in metastatic colorectal cancer to both refine patient selection, reduce toxicity due to chemotherapy, and to evaluate emerging resistance mechanisms may lead the way to novel therapeutic strategies. However, important questions remain in validating its use as a predictive biomarker of treatment response. See related article by Vidal et al., p. 379.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9852066 | PMC |
| http://dx.doi.org/10.1158/1078-0432.CCR-22-2793 | DOI Listing |
Publication Analysis
Top Keywords
serial ctdna
8
truncal dynamics
4
dynamics trump
4
trump serial
4
ctdna predict
4
predict early
4
early therapeutic
4
therapeutic response
4
response promising
4
promising utility
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!